The differences between treatments reached statistical significance at month 3, but did not reach statistical significance at month 6 and 12 (Table 2 and Fig. 6 d).
← all excerpts
Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial.
1
—
—